Aluminum toxicokinetics regarding infant diet and vaccinations.

  title={Aluminum toxicokinetics regarding infant diet and vaccinations.},
  author={L. Samuel Keith and D. E. Jones and C.-H. Selene J. Chou},
  volume={20 Suppl 3},

Figures from this paper

Reconsideration of the immunotherapeutic pediatric safe dose levels of aluminum.
Infants' exposure to aluminum from vaccines and breast milk during the first 6 months
The need to study long-term effects of early exposure to neuro-toxic substances on the developing brain is reinforced, and Pragmatic vaccine safety needs to embrace conventional toxicology, addressing especial characteristics of unborn fetuses, neonates and infants exposed to low levels of aluminum.
Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants.
Towards toxicokinetic modelling of aluminium exposure from adjuvants in medicinal products
Distribution of aluminum in hair of Brazilian infants and correlation to aluminum-adjuvanted vaccine exposure.
Exposure to Mercury and Aluminum in Early Life: Developmental Vulnerability as a Modifying Factor in Neurologic and Immunologic Effects
  • J. Dórea
  • Medicine
    International journal of environmental research and public health
  • 2015
Early life exposure to both EtHg and Al deserves due consideration because the potential synergic effect of both toxic agents has not been properly studied.


[Aluminum as an adjuvant in vaccines and post-vaccine reactions].
Aluminium adjuvant immunogens induce the production of IgE antibodies, which are a more frequent cause of local post-vaccinal reactions than plain vaccines.
In vivo absorption of aluminium-containing vaccine adjuvants using 26Al.
The biological speciation and toxicokinetics of aluminum.
This review discusses recent literature on the chemical and physiological factors that influence the absorption, distribution, and excretion of aluminum in mammals, with particular regard to
Aluminum contamination of infant formulas.
This study aims to determine the extent of aluminum (Al) contamination in whole milk, milk formulas, and other nutrient products commonly used for infants. Similar products from different
Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
  • M. Wills, J. Savory
  • Medicine, Biology
    Critical reviews in clinical laboratory sciences
  • 1989
In patients with end-stage chronic renal failure, particularly in those on treatment by hemodialysis, the accumulation of aluminum in bone, brain, and other tissues is associated with toxic sequelae and an increased brain content of aluminum appears to be the major etiological factor in the development of a neurological syndrome.
Potential Aluminium Toxicity in Infants Fed Special Infant Formula
It is concluded that infants may be at risk from aluminium toxicity when consuming formula containing >300 μg/L–in particular, casein hydrolysate formulae, and that some constituents of infant formula affect aluminium absorption from the gut lumen.
Metabolism and possible health effects of aluminum.
A hypothetical model is presented for the metabolism of aluminum, based on documented direct observations of Al3+ and analogies from other ions, and it is proposed that an accumulation may take place at a subcellular level without any significant increase in the corresponding tissue concentration.
Kinetics of aluminum in rats. II: Dose-dependent urinary and biliary excretion.
In vitro ultrafiltration studies support the hypothesis that decreases in urinary clearance were due to decreased filterability of aluminum at the glomerulus as its blood concentration was increased, and appear to be due to concentration-dependent of transfer from blood to liver, rather than from liver to bile.
Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis.
It is indicated that gastrointestinal absorption of aluminum can lead to aluminum intoxication in children with azotemia, and that infants may be particularly susceptible to this complication of therapy.